NFKB1 and glioblastoma: • Reports regarding the participationof NF-κB in apoptosis, cellularproliferation,angiogenesis, metastasis, invasion, and many other processes implicatedin GBM pathobiology ascertain the candidature of NF-κB regulationas an imperative pharmacological target for the treatment of GBM therapy.